Therapeutic treatment
First Claim
1. A method for increasing the absolute claudication distance in a patient suffering of intermittent claudication or peripheral arterial disease with intermittent claudication, said method comprising administering to said patient, as a therapeutically active agent for increasing the maximal walking distance, a composition comprising as a single active ingredient a therapeutically effective amount of at least one therapeutically active compound selected from the group consisting of betaine of formula (CH3)3N+(CH2)COO−
- , pharmaceutically active salts thereof and mixtures thereof, so as to increase said absolute claudication distance.
0 Assignments
0 Petitions
Accused Products
Abstract
The invention describes the use of betaine for treating and preventing arterites. The invention also describes an orally administered composition for treating arterites and, in particular, intermittent claudication, said composition containing, as an active ingredient, an active therapeutic quantity of betaine glycine by single dose. The invention particularly describes a medicament provided for treating a patient suffering from an intermittent claudication caused by peripheral circulatory disorders such as arteriosclerosis obliterans or by thromboangiitis obliterans.
-
Citations
12 Claims
-
1. A method for increasing the absolute claudication distance in a patient suffering of intermittent claudication or peripheral arterial disease with intermittent claudication, said method comprising administering to said patient, as a therapeutically active agent for increasing the maximal walking distance, a composition comprising as a single active ingredient a therapeutically effective amount of at least one therapeutically active compound selected from the group consisting of betaine of formula (CH3)3N+(CH2)COO−
- , pharmaceutically active salts thereof and mixtures thereof, so as to increase said absolute claudication distance.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
Specification